Tags » HIV

The Gates Foundation invests $ 40 million to support TCR-T therapy

As a leading global TCR company, Immunocore will focus on the development of ImmTAV and ImmTAB molecules for the treatment of tuberculosis (TB) and human immunodeficiency virus (HIV), which is expected to shorten treatment time and improve patient outcomes. 97 more words

HIV

A selective HIV protease inhibitor----Amprenavir

Amprenavir is a novel (fifth generation) antiretroviral inhibitor that acts by blocking the formation of new, mature virions from the infected host cell surface, inhibiting the protease of the virus. 63 more words

Intermediate

HIV testing: encouraging uptake

This quality standard covers interventions to improve the uptake of HIV testing among people who may have undiagnosed HIV. It focuses on increasing testing to reduce undiagnosed infection in people at increased risk of exposure. 9 more words

09 (September 2017)

The first man to be cured of HIV

He wasn’t born to be a public speaker. A slight man, he stood before us, telling his story. He was the first man to be cured of HIV.  763 more words

Health And Disease

B.C. assesses Truvada, an HIV prevention drug that looks 'very promising'

Health experts in B.C. are examining an HIV prevention drug that a Vancouver gay men’s health group wants to see covered provincially.

The drug, called… 458 more words

Health

Hepatitis C eradication and profit

Note: This is a guest blog by Helmut Jäger. Dr Jäger’s website and blog provides more information and thoughtful comments on healthcare issues at: http://www.medizinisches-coaching.net/ 1,600 more words

HIV

50: Young People and HIV Research Discourse

Dr. Beth Vale is a researcher at the Mapungubwe Institute for Strategic Reflection. She is a Mandela Rhodes and a Rhodes Scholar. Dr. Vale was a postdoctoral fellow under the NRF Chair in Local Histories, Present Realities at Wits University. 106 more words

South Africa